跳至主要内容
临床试验/CTRI/2023/03/050492
CTRI/2023/03/050492尚未招募不适用

prevalence of Human Papilloma virus and associated cytological abnormalities in immunocompromised at a tertiary level setting in coastal Karnataka

university grant1 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2023年10月3日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
220
试验地点
1
主要终点
HPV test reports (HPV 16/18/other high risk Positive/ negative

研究概览

简要总结

Primaryobjective:

Theprevalence of cervicovaginal Human Papilloma virus and cytologicalabnormalities of the cervix in immunocompromised women at a tertiary levelsetting in coastal Karnataka

Secondaryobjective:

Tocompare the HPV positivity/ cytological abnormalities against viral load, CD4count, adherence to HAART among retropositive women

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
Female

入选标准

  • Women on immunosuppressant therapy, including long term steroids (≥6 months) Those with confirmed retro-positive status Women with chronic kidney disease.

排除标准

  • Patients who underwent hysterectomy Virgin women Pregnant and postpartum upto 6 weeks.

结局指标

主要结局

HPV test reports (HPV 16/18/other high risk Positive/ negative

时间窗: time bound

Cytologic report- negative/ ASCUS/ ASC-H/ LSIL/HSIL/Invasive carcinoma

时间窗: time bound

次要结局

  • For objective 2, Above variables will be compared with the CD4 count, viral load, adherence to HAART among retropositive women(time bound)

研究者

发起方
university grant
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验